ARTRYA
Artrya uses artificial intelligence to deliver faster and more accurate diagnoses of Coronary Artery Disease. Left undiagnosed, patients remain at risk, incorrect treatment regimes are administered and cost burdens on health systems escalate. With ageing populations and the demand for medical services rising globally, significant delays in reporting can leave patients in critical situations.
ARTRYA
Industry:
Artificial Intelligence (AI) Biotechnology Health Care Health Diagnostics Machine Learning Medical Software
Founded:
2019-01-01
Address:
Perth, Western Australia, Australia
Country:
Australia
Website Url:
http://www.artrya.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
15 M USD
Technology used in webpage:
Domain Not Resolving Font Awesome IPv6 Nginx Cloudflare JS CDN JS AJAX Libraries API U.S. Server Location Ruby On Rails Token Typekit
Similar Organizations
Basecamp Research
Basecamp Research leverages their unprecedented knowledge of the natural world to create better medicines, better food and better products
Brainomix
Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions
DeepCure
DeepCuris builds an AI engine for small-molecule drug discovery.
Delfi Diagnostics
Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.
Infervision
Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
Oscer
Oscer is a clinical training that offers advanced machine learning and artificial intelligence service.
Overjet
Overjet combines deep learning of dental images and data science to empower dental providers and payers to deliver the best patient care.
SeedBlink
SeedBlink is Europe’s fastest growing investing platform specialized in sourcing, vetting, financing and scaling tech start-ups.
Sema4
Sema4 uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Septerna
Septerna is a biotechnology company.
Current Employees Featured
Founder
Stock Details
Investors List
Watermark Funds Management
Watermark Funds Management investment in Series A - Artrya
Washington H. Soul Pattinson
Washington H. Soul Pattinson investment in Series A - Artrya
Thorney Investment
Thorney Investment investment in Series A - Artrya
Regal Funds Management
Regal Funds Management investment in Series A - Artrya
Official Site Inspections
http://www.artrya.com Semrush global rank: 11.48 M Semrush visits lastest month: 159
- Host name: acd89244c803f7181.awsglobalaccelerator.com
- IP address: 75.2.60.5
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Artrya"
Artrya - Crunchbase Company Profile & Funding
Organization. Artrya . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Artrya uses artificial intelligence to deliver …See details»
Who We Are - Artrya
Artrya is an AI-driven MedTech company, founded in 2019, and brought to life in Perth, Australia. Artrya was co-founded by John Konstantopoulos and John Barrington AM, who came together …See details»
Leadership Team | Artrya
As Artrya’s Chief Scientific Officer, Professor Girish Dwivedi, MD is excited to be working within the MedTech industry to innovate and create solutions using advanced technology, such as AI, to improve health. View Profile. Medical …See details»
Artrya Company Profile - Office Locations, Competitors, Revenue …
Oct 16, 2024 Artrya. Stock Price. $0.3. 2024-10-16. Artrya Summary. Company Summary. Overview. Artrya is an artificial intelligence healthcare company. It offers cloud software, …See details»
Artrya Limited (ASX: AYA) Company Profile & Overview - Stock …
Nov 1, 2024 Artrya Limited, a medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address …See details»
Artrya - Company Profile - Tracxn
Oct 16, 2024 Artrya gets to the heart of AI with ASX listing, $40 million IPOProactive • Nov 26, 2021 • Artrya AI medical technology start-up Artrya looking to list TechInvest • Oct 19, 2021 • …See details»
Artrya - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 24, 2024 Organization. Artrya . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 53. Monthly …See details»
Heart disease AI diagnostics med-tech Artrya to list at $105m …
Oct 18, 2021 Artrya managing director and co-founder John Barrington AM says the company is offering investors an exciting opportunity to invest in an innovative business with a mission to …See details»
Investor Relations | Artrya
Company Details. Name: Artrya Limited Incorporated: ACN 624 005 741 Business description: AI-based coronary artery disease Diagnostic support software Registered office: 1257 Hay St …See details»
Artrya Ltd, AYA:ASX profile - FT.com - Financial Times
Nov 20, 2024 Its Artrya Salix is a computed tomography coronary angiography (CCTA) image analysis solution that enables physicians with AI to identify and analyze the extent and type of …See details»
The rise of artificial intelligence in healthcare - Artrya
Website: www.artrya.com Company Synopsis: Artrya Ltd (ASX:AYA) is an AI-driven health-tech company focused on disrupting how coronary artery disease is diagnosed. …See details»
Artrya - Contacts, Employees, Board Members, Advisors & Alumni
Artrya uses artificial intelligence to deliver faster and more accurate diagnoses of Coronary Artery Disease.See details»
ARTRYA OPENS US OPERATIONS IN LOS ANGELES - PR Newswire
Mar 29, 2022 Artrya is an applied artificial intelligence healthcare company that works alongside clinicians to improve the diagnosis of coronary heart disease and develop a holistic overview …See details»
A theatre of human innovation: Artrya | ASX:AYA
Jun 28, 2022 Artrya, a medtech start-up deploying artificial intelligence (AI) for the early detection of coronary artery disease, was born when Barrington and co-founder John …See details»
Company News - Artrya
Dec 28, 2022 Artrya's newsroom is the hub for all news and updates pertaining to Artrya. Our solution. Knowledge hub. About Artrya. Investor Relations. Contact Us Request a …See details»
Artrya Is On The Pulse - MTPConnect
10 Dec 2020 / Case Study Pictured (L-R): the Artrya team – Chief Medical Officer Professor Girish Dwivedi, Executive Chairman John Barrington AM and CEO John Konstantopoulos at the …See details»
Artrya Opens US Operations in California
ASX Announcement 29th March 2022. Perth, Western Australia – Australian medical technology company, Artrya Limited (ASX: AYA, Artrya or the Company) creator of the AI-based solution, …See details»
Medtech company Artrya to roll out AI heart disease detecting …
Oct 4, 2021 Artrya noted that around nine million individuals die each year from coronary artery disease. In Australia, it was the single leading cause of death in 2018, accounting for 42% of …See details»
Contact Us - Artrya
Contact Artrya to learn more about how Artrya is partnering with to diagnose coronary artery disease, at speed, for patients presenting with chest pain. Our solution. Knowledge hub. About …See details»